|
English
|
正體中文
|
简体中文
|
2815037
|
|
???header.visitor??? :
27356183
???header.onlineuser??? :
719
???header.sponsordeclaration???
|
|
|
???tair.name??? >
???browser.page.title.author???
|
"marriott v"???jsp.browse.items-by-author.description???
Showing items 1-1 of 1 (1 Page(s) Totally) 1 View [10|25|50] records per page
國家衛生研究院 |
2014-05 |
A phase I dose escalation study of weekly BI 836845, a fully human, affinity-optineized, insulin -like growth factor (IGF) ligand neutralizing antibody, in patients with advanced solid cancers
|
Lin, CC;Chang, KY;Huang, DC;Marriott, V;Beijsterveldt, L;Chen, LT;Chang, AL |
Showing items 1-1 of 1 (1 Page(s) Totally) 1 View [10|25|50] records per page
|